|
|
白蛋白在肝硬化治疗中的应用及有效白蛋白概念解读
|
Abstract:
肝硬化是一种由肝脏炎症及纤维化引起的慢性疾病，是一种连续、动态性、进行性肝病。肝硬化是肝组织的病理性瘢痕，导致肝功能受损，它可以由慢性肝病的任何病因引起，并引起严重的疾病负担，通过控制病因，消除诱因可以改善肝硬化预后，控制病情进展，全身炎症在肝硬化发生中有着不可忽略的作用。血清白蛋白可以治疗并发症，改善患者生活质量，改善全身炎症，维持血管内皮稳定，改善循环系统障碍，对于患者有较大益处，但目前对于白蛋白使用有较大争议，且有效白蛋白概念未得到普及，本文就白蛋白在肝硬化治疗中价值及有效白蛋白进行综述，期望能对肝硬化患者诊疗提供思路。
Liver cirrhosis is a chronic, dynamic and progressive liver disease caused by inflammation and fi-brosis of the liver. Liver cirrhosis is a pathological scar of liver tissue, resulting in impaired liver function, it can be caused by any cause of chronic liver disease, and cause a serious disease burden, by controlling the cause, eliminating the cause can improve the prognosis of cirrhosis, control the progression of the disease, systemic inflammation has a non-negligible role in the onset of cirrhosis. Serum albumin can treat complications, improve the quality of life of patients, improve systemic in-flammation, maintain vascular endothelial stability, improve circulatory system disorders, and have great benefits for patients, but at present, the use of albumin is controversial, and the concept of effective albumin has not been popularized, this article reviews the value of albumin in the treatment of liver cirrhosis and effective albumin, hoping to provide ideas for the diagnosis and treatment of patients with liver cirrhosis.
| [1] | GBD 2019 Diseases and Injuries Collaborators (2020) Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204-1222.
https://doi.org/10.1016/S0140-6736(20)30925-9 |
| [2] | Quinlan, G.J., Martin, G.S. and Evans, T.W. (2005) Albu-min: Biochemical Properties and Therapeutic Potential. Hepatology, 41, 1211-1219. https://doi.org/10.1002/hep.20720 |
| [3] | Bernardi, M., Angeli, P., Claria, J., Moreau, R., Gines, P., Jalan, R., Cara-ceni, P., Fernandez, J., Gerbes, A.L., O’Brien, A.J., Trebicka, J., Thevenot, T. and Arroyo, V. (2020) Albumin in De-compensated Cirrhosis: New Concepts and Perspectives. Gut, 69, 1127-1138. https://doi.org/10.1136/gutjnl-2019-318843 |
| [4] | Garcia-Martinez, R., Caraceni, P., Bernardi, M., Gines, P., Arroyo, V. and Jalan, R. (2013) Albumin: Pathophysiologic Basis of Its Role in the Treatment of Cirrhosis and Its Complications. Hepatology, 58, 1836-1846.
https://doi.org/10.1002/hep.26338 |
| [5] | Bernardi, M., Moreau, R., Angeli, P., Schnabl, B. and Arroyo, V. (2015) Mechanisms of Decompensation and Organ Failure in Cirrhosis: From Peripheral Arterial Vasodilation to Systemic In-flammation Hypothesis. Journal of Hepatology, 63, 1272-1284. https://doi.org/10.1016/j.jhep.2015.07.004 |
| [6] | Moreau, R., Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., Gerbes, A., Wendon, J., Alessandria, C., Laleman, W., Zeuzem, S., Trebicka, J., Bernardi, M. and Arroyo, V. (2013) Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients with Acute Decompensation of Cirrhosis. Gastroenterology, 144, 1426-1437. https://doi.org/10.1053/j.gastro.2013.02.042 |
| [7] | Clària, J., Stauber, R.E., Coenraad, M.J., Moreau, R., Jalan, R., Pavesi, M., Amorós, à., Titos, E., Alcaraz-Quiles, J., Oettl, K., Morales-Ruiz, M., Angeli, P., Domenicali, M., Alessan-dria, C., Gerbes, A., Wendon, J., Nevens, F., Trebicka, J., Laleman, W., Saliba, F., Welzel, T.M., Albillos, A., Gustot, T., Benten, D., Durand, F., Ginès, P., Bernardi, M. and Arroyo, V. (2016) Systemic Inflammation in Decompensated Cir-rhosis: Characterization and Role in Acute-on-Chronic Liver Failure. Hepatology, 64, 1249-1264. https://doi.org/10.1002/hep.28740 |
| [8] | Trebicka, J., Fernandez, J., Papp, M., Caraceni, P., Laleman, W., Gambino, C., Giovo, I., Uschner, F.E., Jimenez, C., Mookerjee, R., Gustot, T., Albillos, A., Ba？ares, R., Janicko, M., Steib, C., Reiberger, T., Acevedo, J., Gatti, P., Bernal, W., Zeuzem, S., Zipprich, A., Piano, S., Berg, T., Bruns, T., Bendtsen, F., Coenraad, M., Merli, M., Stauber, R., Zoller, H., Ramos, JP., Solè, C., Soriano, G., de, Gottardi, A., Gronbaek, H., Saliba, F., Trautwein, C., ？zdogan, O.C., Francque, S., Ryder, S., Nahon, P., Romero-Gomez, M., Van Vlierberghe, H., Francoz, C., Manns, M., Garcia, E., Tufoni, M., Amoros, A., Pavesi, M., Sanchez, C., Curto, A., Pitarch, C., Putignano, A., Moreno, E., Shawcross, D., Aguilar, F., Clària, J., Ponzo, P., Jansen, C., Vitalis, Z., Zaccherini, G., Balogh, B., Vargas, V., Montagnese, S., Alessandria, C., Bernardi, M., Ginès, P., Jalan, R., Moreau, R., Angeli, P. and Arroyo, V. (2020) The PREDICT Study Uncovers Three Clinical Courses of Acutely Decompensated Cirrhosis That Have Distinct Pathophysiology. Journal of Hepatology, 73, 842-854. https://doi.org/10.1016/j.jhep.2020.06.013 |
| [9] | Jalan, R., Schnurr, K., Mookerjee, R.P., Sen, S., Cheshire, L., Hodges, S., Muravsky, V., Williams, R., Matthes, G. and Davies, N.A. (2009) Alterations in the Functional Capacity of Albumin in Patients with Decompensated Cirrhosis Is Associated with Increased Mortality. Hepatology, 50, 555-564. https://doi.org/10.1002/hep.22913 |
| [10] | European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis. Journal of Hepatology, 69, 406-460. https://doi.org/10.1016/j.jhep.2018.03.024 |
| [11] | Moore, K.P., Wong, F., Gines, P., Bernardi, M., Ochs, A., Salerno, F., Angeli, P., Porayko, M., Moreau, R., Garcia-Tsao, G., Jimenez, W., Planas, R. and Arroyo, V. (2003) The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club. Hepatology, 38, 258-266.
https://doi.org/10.1053/jhep.2003.50315 |
| [12] | Biggins, S.W., Angeli, P., Garcia-Tsao, G., Ginès, P., Ling, S.C., Nadim, M.K., Wong, F. and Kim, W.R. (2021) Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacte-rial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 74, 1014-1048.
https://doi.org/10.1002/hep.31884 |
| [13] | Ruiz-del-Arbol, L., Monescillo, A., Jimenéz, W., Garcia-Plaza, A., Arroyo, V. and Rodés, J. (1997) Paracentesis-Induced Circulatory Dysfunction: Mechanism and Effect on Hepatic Hemodynam-ics in Cirrhosis. Gastroenterology, 113, 579-586.
https://doi.org/10.1053/gast.1997.v113.pm9247479 |
| [14] | Ginès, P., Titó, L., Arroyo, V., Planas, R., Panés, J., Viver, J., Torres, M., Humbert, P., Rimola, A. and Llach, J. (1988) Randomized Comparative Study of Therapeutic Pa-racentesis with and without Intravenous Albumin in Cirrhosis. Gastroenterology, 94, 1493-1502. https://doi.org/10.1016/0016-5085(88)90691-9 |
| [15] | Bernardi, M., Ricci, C.S. and Zaccherini, G. (2014) Role of Human Albumin in the Management of Complications of Liver Cirrhosis. Journal of Clinical and Experimental Hepa-tology, 4, 302-311.
https://doi.org/10.1016/j.jceh.2014.08.007 |
| [16] | Zaccherini, G., Tufoni, M., Iannone, G. and Caraceni, P. (2021) Management of Ascites in Patients with Cirrhosis: An Update. Journal of Clinical Medicine, 10, Article No. 5226. https://doi.org/10.3390/jcm10225226 |
| [17] | Ginès, A., Fernández-Esparrach, G., Monescillo, A., Vila, C., Domènech, E., Abecasis, R., Angeli, P., Ruiz-Del-Arbol, L., Planas, R., Solà, R., Ginès, P., Terg, R., Inglada, L., Vaqué, P., Salerno, F., Vargas, V., Clemente, G., Quer, J.C., Jiménez, W., Arroyo, V. and Rodés, J. (1996) Randomized Trial Comparing Albumin, Dextran 70, and Polygeline in Cirrhotic Patients with Ascites Treated by Paracentesis. Gastroen-terology; 111, 1002-1010.
https://doi.org/10.1016/S0016-5085(96)70068-9, |
| [18] | Sola-Vera, J., Mi？ana, J., Ricart, E., Planella, M., González, B., Torras, X., Rodríguez, J., Such, J., Pascual, S., Soriano, G., Pérez-Mateo, M. and Guarner, C. (2003) Randomized Trial Comparing Albumin and Saline in the Prevention of Paracentesis-Induced Circulatory Dysfunction in Cirrhotic Pa-tients with Ascites. Hepatology, 37, 1147-1153.
https://doi.org/10.1053/jhep.2003.50169 |
| [19] | Moreau, R., Valla, D.-C., Durand-Zaleski, I., Bronowicki, J.-P., Du-rand, F., Chaput, J.-C., Dadamessi, I., Silvain, C., Bonny, C., Oberti, F., Gournay, J., Lebrec, D., Grouin, J.-M., Guémas, E., Golly, D., Padrazzi, B. and Tellier, Z. (2006) Comparison of Outcome in Patients with Cirrhosis and Ascites Follow-ing Treatment with Albumin or a Synthetic Colloid: A Randomised Controlled Pilot Trial. Liver International, 26, 46-54.
https://doi.org/10.1111/j.1478-3231.2005.01188.x |
| [20] | Hamdy, H., ElBaz, A.A., Hassan, A. and Hassanin, O. (2014) Comparison of Midodrine and Albumin in the Prevention of Paracentesis-Induced Circulatory Dysfunction in Cirrhotic Patients: A Randomized Pilot Study. Journal of Clinical Gastroenterology, 48, 184-188. https://doi.org/10.1097/MCG.0b013e31829ae376 |
| [21] | Fagundes, C., Barreto, R., Guevara, M., Garcia, E., Solà, E., Rodríguez, E., Graupera, I., Ariza, X., Pereira, G., Alfaro, I., Cárdenas, A., Fernández, J., Poch, E. and Ginès, P. (2013) A Modified Acute Kidney Injury Classification for Diagnosis and Risk Stratification of Impairment of Kidney Function in Cirrhosis. Journal of Hepatology, 59, 474-481.
https://doi.org/10.1016/j.jhep.2013.04.036 |
| [22] | Angeli, P., Ginès, P., Wong, F., Bernardi, M., Boyer, T.D., Gerbes, A., Moreau, R., Jalan, R., Sarin, S.K., Piano, S., Moore, K., Lee, S.S., Durand, F., Salerno, F., Caraceni, P., Kim, W.R., Arroyo, V. and Garcia-Tsao, G. (2015) Diagnosis and Management of Acute Kidney Injury in Patients with Cirrhosis: Revised Consensus Recommendations of the International Club of Ascites. Journal of Hepatology, 62, 968-974. https://doi.org/10.1016/j.jhep.2014.12.029 |
| [23] | Flamm, S.L., Wong, F., Ahn, J. and Kamath, P.S. (2022) AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients with Cirrhosis: Expert Review. Clinical Gastroenterology and Hepatology, 20, 2707-2716. https://doi.org/10.1016/j.cgh.2022.08.033 |
| [24] | Velez, J.C.Q. (2022) Hepatorenal Syndrome Type 1: From Diagno-sis Ascertainment to Goal-Oriented Pharmacologic Therapy. Kidney360, 3, 382-395. https://doi.org/10.34067/KID.0006722021 |
| [25] | Cantin, A.M., Paquette, B., Richter, M. and Larivée, P. (2000) Al-bumin-Mediated Regulation of Cellular Glutathione and Nuclear Factor Kappa B Activation. American Journal of Res-piratory and Critical Care Medicine, 162, 1539-1546.
https://doi.org/10.1164/ajrccm.162.4.9910106 |
| [26] | Ortega, R., Ginès, P., Uriz, J., Cárdenas, A., Calahorra, B., De Las Heras, D., Guevara, M., Bataller, R., Jiménez, W., Arroyo, V. and Rodés, J. (2002) Terlipressin Therapy with and without Albumin for Patients with Hepatorenal Syndrome: Results of a Prospective, Nonrandomized Study. Hepatology, 36, 941-948.
https://doi.org/10.1053/jhep.2002.35819 |
| [27] | Fernández, J., Monteagudo, J., Bargallo, X., Jiménez, W., Bosch, J., Arroyo, V. and Navasa, M. (2005) A Randomized Unblinded Pilot Study Comparing Albumin versus Hydroxyethyl Starch in Spontaneous Bacterial Peritonitis. Hepatology, 42, 627-634. https://doi.org/10.1002/hep.20829 |
| [28] | Antoniades, C. and Auzinger, G. (2003) Terlipressin and Albumin for the Hepatorenal Syndrome. Hepatology, 37, 946.
https://doi.org/10.1053/jhep.2003.50108 |
| [29] | Wong, F., Pappas, S.C., Curry, M.P., Reddy, K.R., Rubin, R.A., Porayko, M.K., Gonzalez, S.A., Mumtaz, K., Lim, N., Simonetto, D.A., Sharma, P., Sanyal, A.J., Mayo, M.J., Frederick, R.T., Escalante, S. and Jamil, K. (2021) Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. New England Journal of Medicine, 384, 818-828.
https://doi.org/10.1056/NEJMoa2008290 |
| [30] | Song, D.S. (2018) Spontaneous Bacterial Peritonitis. The Korean Journal of Gastroenterology, 72, 56-63.
https://doi.org/10.4166/kjg.2018.72.2.56 |
| [31] | Maraolo, A.E., Gentile, I., Pinchera, B., Nappa, S. and Borgia, G. (2018) Current and Emerging Pharmacotherapy for the Treatment of Bacterial Peritonitis. Expert Opinion on Pharma-cotherapy, 19, 1317-1325.
https://doi.org/10.1080/14656566.2018.1505867 |
| [32] | Mattos, A.A., Wiltgen, D., Jotz, R.F., Dornelles, C.M.R., Fernandes, M.V. and Mattos, ？.Z. (2020) Spontaneous Bacterial Peritonitis and Extraperitoneal Infections in Patients with Cirrhosis. Annals of Hepatology, 19, 451-457.
https://doi.org/10.1016/j.aohep.2020.04.010 |
| [33] | Gustot, T., Felleiter, P., Pickkers, P., Sakr, Y., Rello, J., Velis-saris, D., Pierrakos, C., Taccone, F.S., Sevcik, P., Moreno, C. and Vincent, J.L. (2014) Impact of Infection on the Prog-nosis of Critically Ill Cirrhotic Patients: Results from a Large Worldwide Study. Liver International, 34, 1496-1503. https://doi.org/10.1111/liv.12520 |
| [34] | Sort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruiz-del-Arbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., Ginès, P. and Rodés, J. (1999) Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. New England Journal of Medicine, 341, 403-409.
https://doi.org/10.1056/NEJM199908053410603 |
| [35] | Chen, T.-A., Tsao, Y.-C., Chen, A., Lo, G.-H., Lin, C.-K., Yu, H.-C., Cheng, L.-C., Hsu, P.-I. and Tsai, W.-L. (2009) Effect of Intravenous Albumin on Endotoxin Removal, Cy-tokines, and Nitric Oxide Production in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. Scandinavian Journal of Gastroenterology, 44, 619-625.
https://doi.org/10.1080/00365520902719273 |
| [36] | Aithal, G.P., Palaniyappan, N., China, L., H？rm？l？, S., Macken, L., Ryan, J.M., Wilkes, E.A., Moore, K., Leithead, J.A., Hayes, P.C., O’Brien, A.J. and Verma, S. (2021) Guidelines on the Management of Ascites in Cirrhosis. Gut, 70, 9-29. https://doi.org/10.1136/gutjnl-2020-321790 |
| [37] | Piano, S. and Angeli, P. (2021) Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation? Clinics in Liver Disease, 25, 357-372. https://doi.org/10.1016/j.cld.2021.01.006 |
| [38] | Wong, Y.-J., Qiu, T.-Y., Tam, Y.-C., Mohan, B.P., Gallegos-Orozco, J.F. and Adler, D.G. (2020) Efficacy and Safety of IV Albumin for Non-Spontaneous Bacterial Peritonitis Infection among Patients with Cirrhosis: A Systematic Review and Meta-Analysis. Digestive and Liver Dis-ease, 52, 1137-1142. https://doi.org/10.1016/j.dld.2020.05.047 |
| [39] | Casulleras, M., Flores-Costa, R., Duran-Güell, M., Alcaraz-Quiles, J., Sanz, S., Titos, E., López-Vicario, C., Fernández, J., Horrillo, R., Costa, M., de, la, Grange, P., Moreau, R., Arroyo, V. and Clària, J. (2020) Albumin Internalizes and Inhibits Endosomal TLR Signaling in Leukocytes From Patients with Decompensated Cirrhosis. Science Translational Medicine, 12. https://doi.org/10.1126/scitranslmed.aax5135 |
| [40] | Jalan, R. and Kapoor, D. (2004) Reversal of Diuretic-Induced Hepatic Encephalopathy with Infusion of Albumin but Not Colloid. Clinical Science, 106, 467-474. https://doi.org/10.1042/CS20030357 |
| [41] | Riggio, O., Nardelli, S., Pasquale, C., Pentassuglio, I., Gioia, S., Onori, E., Frieri, C., Salvatori, F.M. and Merli, M. (2016) No Effect of Albumin Infusion on the Prevention of Hepatic Enceph-alopathy after Transjugular Intrahepatic Portosystemic Shunt. Metabolic Brain Disease, 31, 1275-1281. https://doi.org/10.1007/s11011-015-9713-x |
| [42] | Parving, H.-H., Ranek, L. and Lassen, N.A. (1977) Increased Transcapillary Escape Rate of Albumin in Patients with Cirrhosis of the Liver. Scandinavian Journal of Clinical and La-boratory Investigation, 37, 643-648.
https://doi.org/10.3109/00365517709100658 |
| [43] | McCormick, P.A., Mistry, P., Kaye, G., Burroughs, A.K. and McIntyre, N. (1990) Intravenous Albumin Infusion Is an Effective Therapy for Hyponatraemia in Cirrhotic Patients with Ascites. Gut, 31, 204-207.
https://doi.org/10.1136/gut.31.2.204 |
| [44] | China, L., Freemantle, N., Forrest, E., Kallis, Y., Ryder, S.D., Wright, G., Portal, A.J., Becares Salles, N., Gilroy, D.W. and O’Brien, A. (2021) A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. New England Journal of Medicine, 384, 808-817. https://doi.org/10.1056/NEJMoa2022166 |
| [45] | Bortoluzzi, A., Ceolotto, G., Gola, E., Sticca, A., Bova, S., Morando, F., Piano, S., Fasolato, S., Rosi, S., Gatta, A. and Angeli, P. (2013) Positive Cardiac Inotropic Effect of Albumin Infu-sion in Rodents with Cirrhosis and Ascites: Molecular Mechanisms. Hepatology, 57, 266-276. https://doi.org/10.1002/hep.26021 |
| [46] | Martens, K., McMurry, H.S., Koprowski, S., Hum, J., Haraga, J., Jou, J.H. and Shatzel, J.J. (2022) Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Appli-cations for Prophylactic Therapy. Journal of Clinical Gastroenterology, 56, 536-545. https://doi.org/10.1097/MCG.0000000000001713 |
| [47] | Fernández, J., Clària, J., Amorós, A., Aguilar, F., Castro, M., Casulleras, M., Acevedo, J., Duran-Güell, M., Nu？ez, L., Costa, M., Torres, M., Horrillo, R., Ruiz-Del-árbol, L., Villanueva, C., Prado, V., Arteaga, M., Trebicka, J., Angeli, P., Merli, M., Alessandria, C., Aagaard, N.K., Soriano, G., Durand, F., Gerbes, A., Gustot, T., Welzel, T.M., Salerno, F., Ba？ares, R., Vargas, V., Albillos, A., Silva, A., Mo-rales-Ruiz, M., Carlos, García-Pagán, J., Pavesi, M., Jalan, R., Bernardi, M., Moreau, R., Páez, A. and Arroyo, V. (2019) Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients with De-compensated Cirrhosis. Gastroenterology, 157, 149-162.
https://doi.org/10.1053/j.gastro.2019.03.021 |
| [48] | Baldassarre, M., Naldi, M., Zaccherini, G., Bartoletti, M., An-tognoli, A., Laggetta, M., Gagliardi, M., Tufoni, M., Domenicali, M., Waterstradt, K., Paterini, P., Baldan, A., Leoni, S., Bartolini, M., Viale, P., Trevisani, F., Bernardi, M. and Caraceni, P. (2021) Determination of Effective Albumin in Pa-tients with Decompensated Cirrhosis: Clinical and Prognostic Implications. Hepatology, 74, 2058-2073. https://doi.org/10.1002/hep.31798 |
| [49] | Baldassarre, M., Domenicali, M., Naldi, M., Laggetta, M., Giannone, F.A., Biselli, M., Patrono, D., Bertucci, C., Bernardi, M. and Caraceni, P. (2016) Albumin Homodimers in Patients with Cir-rhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule. Scientific Reports, 6, Article No. 35987.
https://doi.org/10.1038/srep35987 |
| [50] | Grüngreiff, K., Gottstein, T., Reinhold, D. and Blindauer, C.A. (2021) Al-bumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc. Nutrients, 13, Article No. 4011. https://doi.org/10.3390/nu13114011 |
